School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Bruce Ribner MD/MPH

  • Department of Medicine
    Professor Emeritus
  • (404) 727-1580
  • bribner@emory.edu
  • Health Sciences Research Building
    Division of Infectious Diseases
    1760 Haygood Drive NE, Suite W319
Head shot of Bruce Ribner

Overview

Dr. Ribner held faculty positions between 1983-2000, at the University of Texas Health Science Center at Houston Medical School, at Duke University Medical School and the Medical University of South Carolina, Charleston.

Dr. Ribner joined the Emory University School of Medicine in 2000 as the Epidemiologist for the Emory University Hospital, and assistant director of the Occupational Injury Department of Emory Healthcare.

Research and Service

Bruce S Ribner, MD, M.P.H., is a Professor of Medicine in Infectious Diseases at the Emory University School of Medicine, and Medical Director of the Emory University Hospital Serious Communicable Diseases Unit. He is one of the Epidemiologists for Emory University Hospital and the Emory Clinic.

As Medical Director of the Serious Communicable Diseases Unit at Emory University Hospital, he is responsible for overall functioning of the Unit and the care of patients treated for Ebola virus disease and other special pathogens. He is also one of the clinicians who provides direct patient care for the Unit.

Dr. Ribner is the principal investigator for the ASPR contract that established Emory University Hospital as the regional Ebola and other special pathogen treatment center for federal region 4. He is the Principal Investigator for a contract with ASPR and CDC for the consortium of Emory University, the University of Nebraska Medical Center, and the New York Health and Hospitals Corporation, establishing the National Ebola Training and Education Center (NETEC).

Dr. Ribner is a member of the Working Group of the Scientific Interactions Subcommittee of the National Interagency Biodefense Campus and a member of the Working group on guidance for clinical management of filovirus and arenavirus hemorrhagic fevers for the National Institute for Allergy and Infectious Diseases. He also serves on the Occupational Exposure on Call Consult Committee for the Intramural Clinical Management & Operations Branch (ICMOB) of the Division of Clinical Research, National Institute for Allergy and Infectious Diseases.

Previously, he has served as PI or Co-PI on more than 20 federal or non-federal research projects.

He is the author of more than 64 peer review publications in outstanding journals including The New England Journal of Medicine, Clinical Microbiology, Infection Control Hospital Epidemiology, and Annuals of Internal Medicine. He has written 15 book chapters, and 1 set of guidelines. He has received numerous honors and recognitions.

His service, dedication, and contributions to infection control and hospital epidemiology at Emory have been and continue to be significant; as evidenced by the American Nursing Association when they voted Emory Healthcare as one of the 3 best programs in the United States.

Dr. Ribner was voted as one of 4 best infectious disease physicians in Atlanta by other physicians in 2005, 2007, and 2009 through 2017.

Teaching

Dr. Ribner serves as a teacher, role model and mentor to medical students, residents, and fellows. He has taught medical students classes from 1991 to the present and been very active in graduate programs. He currently lectures Infectious Diseases fellows, residents for the noon Internal Medicine series, the Rollins School of Public Health in hospital epidemiology, and the nurse anesthetist training program. He supervises fellows, medical residents and medical students on the Infectious Diseases Consult service at the Emory University Hospital, and the Emory Clinic.

Interests

*Hospital epidemiology
*Prevention and management of serious communicable diseases

Academic Appointment

  • Master Clinician, Emory University School of Medicine
  • Professor of Medicine, Division of Infectious Diseases, Emory University, School of Medicine

Education

Degrees

  • MPH from University of Michigan
  • MD from Harvard Medical School
  • A.B. from Princeton University

Research

Focus

  • My research focus has been in two major areas. The first of these has been the defining of risk factors, designing of interventions for prevention, and evaluating newer agents for the treatment of resistant, hospital acquired, organisms.

Publications

  • Approach to Cataract Surgery in an Ebola Virus Disease Survivor with Prior Ocular Viral Persistence.
    Emerg Infect Dis Volume: 26 Page(s): 1553 - 1556
    07/01/2020 Authors: Wells JR; Crozier I; Kraft CS; Sexton ME; Hill CE; Ribner BS; Bavari S; Palacios G; Pearce WA; Van Gelder R
  • Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States.
    Infect Control Hosp Epidemiol Volume: 41 Page(s): 385 - 390
    04/01/2020 Authors: Kraft CS; Mehta AK; Varkey JB; Lyon GM; Vanairsdale S; Bell S; Burd EM; Sexton ME; Cassidy LA; Olinger P
  • New filovirus disease classification and nomenclature.
    Nat Rev Microbiol Volume: 17 Page(s): 261 - 263
    05/01/2019 Authors: Kuhn JH; Adachi T; Adhikari NKJ; Arribas JR; Bah IE; Bausch DG; Bhadelia N; Borchert M; Brantster AB; Brett-Major DM
  • Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.
    Emerg Infect Dis Volume: 25 Page(s): 290 - 298
    02/01/2019 Authors: McElroy AK; Shrivastava-Ranjan P; Harmon JR; Martines RB; Silva-Flannery L; Flietstra TD; Kraft CS; Mehta AK; Lyon GM; Varkey JB
  • Activated macrophages as pathogenesis factors in Ebola virus disease in humans
    Volume: 200
    05/01/2018 Authors: McElroy AK; Shrivastava-Ranjan P; Harmon JR; Martines R; Silva-Flannery L; Flietstra TD; Kraft CS; Mehta AK; Lyon GM; Varkey J
  • New Lineage of Lassa Virus, Togo, 2016.
    Emerg Infect Dis Volume: 24 Page(s): 599 - 602
    03/01/2018 Authors: Whitmer SLM; Strecker T; Cadar D; Dienes H-P; Faber K; Patel K; Brown SM; Davis WG; Klena JD; Rollin PE
  • Ebola Infection in Pregnancy: A Global Perspective and Lessons Learned.
    Clin Obstet Gynecol Volume: 61 Page(s): 186 - 196
    03/01/2018 Authors: Haddad LB; Horton J; Ribner BS; Jamieson DJ
  • Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
    Clin Infect Dis Volume: 65 Page(s): 855 - 859
    09/01/2017 Authors: Raabe VN; Kann G; Ribner BS; Morales A; Varkey JB; Mehta AK; Lyon GM; Vanairsdale S; Faber K; Becker S
  • A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
    J Infect Dis Volume: 215 Page(s): 1862 - 1872
    06/15/2017 Authors: McElroy AK; Akondy RS; Harmon JR; Ellebedy AH; Cannon D; Klena JD; Sidney J; Sette A; Mehta AK; Kraft CS
  • The National Ebola Training and Education Center: Preparing the United States for Ebola and Other Special Pathogens.
    Health Secur Volume: 15 Page(s): 253 - 260
    01/01/2017 Authors: Kratochvil CJ; Evans L; Ribner BS; Lowe JJ; Harvey MC; Hunt RC; Tumpey AJ; Fagan RP; Schwedhelm MM; Bell S
  • Clinical Management of Patients with Ebola Virus Disease in High-Resource Settings.
    Curr Top Microbiol Immunol Volume: 411 Page(s): 115 - 137
    01/01/2017 Authors: Marshall Lyon G; Mehta AK; Ribner BS
  • Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.
    Ophthalmology Volume: 123 Page(s): 2626 - 2628.e2
    12/01/2016 Authors: Shantha JG; Crozier I; Varkey JB; Kraft CS; Lyon GM; Mehta AK; Carlson RD; Hill CE; Kumar G; Debiec MR
  • Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.
    Clin Infect Dis Volume: 63 Page(s): 460 - 467
    08/15/2016 Authors: McElroy AK; Harmon JR; Flietstra TD; Campbell S; Mehta AK; Kraft CS; Lyon MG; Varkey JB; Ribner BS; Kratochvil CJ
  • Ebola Virus Persistence in Semen of Male Survivors.
    Clin Infect Dis Volume: 62 Page(s): 1552 - 1555
    06/15/2016 Authors: Uyeki TM; Erickson BR; Brown S; McElroy AK; Cannon D; Gibbons A; Sealy T; Kainulainen MH; Schuh AJ; Kraft CS
  • Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us.
    Microbiol Spectr Volume: 4
    06/01/2016 Authors: Varkey JB; Ribner BS
  • Clinical Management of Ebola Virus Disease in the United States and Europe.
    N Engl J Med Volume: 374 Page(s): 636 - 646
    02/18/2016 Authors: Uyeki TM; Mehta AK; Davey RT; Liddell AM; Wolf T; Vetter P; Schmiedel S; Grnewald T; Jacobs M; Arribas JR
  • Comparison of FilmArray and Quantitative Real-Time Reverse Transcriptase PCR for Detection of Zaire Ebolavirus from Contrived and Clinical Specimens.
    J Clin Microbiol Volume: 53 Page(s): 2956 - 2960
    09/01/2015 Authors: Southern TR; Racsa LD; Albario CG; Fey PD; Hinrichs SH; Murphy CN; Herrera VL; Sambol AR; Hill CE; Ryan EL
  • The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.
    Clin Infect Dis Volume: 61 Page(s): 496 - 502
    08/15/2015 Authors: Kraft CS; Hewlett AL; Koepsell S; Winkler AM; Kratochvil CJ; Larson L; Varkey JB; Mehta AK; Lyon GM; Friedman-Moraco RJ
  • Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons 18 Years Old.
    J Infect Dis Volume: 212 Page(s): 552 - 561
    08/15/2015 Authors: Keitel WA; Jackson LA; Edupuganti S; Winokur PL; Mulligan MJ; Thornburg NJ; Patel SM; Rouphael NG; Lai L; Bangaru S
  • Ebola virus disease: preparedness and infection control lessons learned from two biocontainment units.
    Curr Opin Infect Dis Volume: 28 Page(s): 343 - 348
    08/01/2015 Authors: Hewlett AL; Varkey JB; Smith PW; Ribner BS
  • Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States.
    Ann Intern Med Volume: 163 Page(s): 81 - 90
    07/21/2015 Authors: Liddell AM; Davey RT; Mehta AK; Varkey JB; Kraft CS; Tseggay GK; Badidi O; Faust AC; Brown KV; Suffredini AF
  • Ebola Virus Disease: Experience and Decision Making for the First Patients outside of Africa.
    PLoS Med Volume: 12 Page(s): e1001857
    07/01/2015 Authors: Stephens DS; Ribner BS; Gartland BD; Feistritzer NR; Farley MM; Larsen CP; Fox JT
  • Environmental infection control considerations for Ebola.
    Am J Infect Control Volume: 43 Page(s): 747 - 749
    07/01/2015 Authors: Lowe JJ; Olinger PL; Gibbs SG; Rengarajan K; Beam EL; Boulter KC; Schwedhelm MM; Hayes AK; Kratochvil CJ; Vanairsdale S
  • Persistence of Ebola Virus in Ocular Fluid during Convalescence.
    N Engl J Med Volume: 372 Page(s): 2423 - 2427
    06/18/2015 Authors: Varkey JB; Shantha JG; Crozier I; Kraft CS; Lyon GM; Mehta AK; Kumar G; Smith JR; Kainulainen MH; Whitmer S
  • Performance of bedside diagnostic ultrasound in an Ebola isolation unit: the Emory University Hospital experience.
    AJR Am J Roentgenol Volume: 204 Page(s): 1157 - 1159
    06/01/2015 Authors: Moreno CC; Kraft CS; Vanairsdale S; Kandiah P; Klopman MA; Ribner BS; Tridandapani S
  • Human Ebola virus infection results in substantial immune activation.
    Proc Natl Acad Sci U S A Volume: 112 Page(s): 4719 - 4724
    04/14/2015 Authors: McElroy AK; Akondy RS; Davis CW; Ellebedy AH; Mehta AK; Kraft CS; Lyon GM; Ribner BS; Varkey J; Sidney J
  • Successful delivery of RRT in Ebola virus disease.
    J Am Soc Nephrol Volume: 26 Page(s): 31 - 37
    01/01/2015 Authors: Connor MJ; Kraft C; Mehta AK; Varkey JB; Lyon GM; Crozier I; Strher U; Ribner BS; Franch HA
  • Clinical care of two patients with Ebola virus disease in the United States.
    N Engl J Med Volume: 371 Page(s): 2402 - 2409
    12/18/2014 Authors: Lyon GM; Mehta AK; Varkey JB; Brantly K; Plyler L; McElroy AK; Kraft CS; Towner JS; Spiropoulou C; Strher U
  • Safe management of patients with serious communicable diseases: recent experience with Ebola virus.
    Ann Intern Med Volume: 161 Page(s): 829 - 830
    12/02/2014 Authors: Isakov A; Jamison A; Miles W; Ribner B
  • A cluster of mucormycosis infections in hematology patients: challenges in investigation and control of invasive mold infections in high-risk patient populations.
    Diagn Microbiol Infect Dis Volume: 71 Page(s): 72 - 80
    09/01/2011 Authors: Llata E; Blossom DB; Khoury HJ; Rao CY; Wannemuehler KA; Noble-Wang J; Langston AA; Ribner BS; Lyon GM; Arnold KE
  • A Web-based program to ensure compliance of medical staff providers with mandated health care facility requirements.
    Am J Infect Control Volume: 39 Page(s): 511 - 514
    08/01/2011 Authors: Ribner BS; Hall C; Steinberg JP; Bornstein WA; Beasley K; Duffell JM; De Gennaro M; Garner D
  • Hepatitis B vaccination coverage and documented seroprotection among matriculating healthcare students at an academic institution in the United States.
    Infect Control Hosp Epidemiol Volume: 32 Page(s): 818 - 821
    08/01/2011 Authors: Tohme RA; Ribner B; Huey MJ; Spradling PR
  • Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.
    J Clin Microbiol Volume: 49 Page(s): 1169 - 1170
    03/01/2011 Authors: Shak JR; Whitaker JA; Ribner BS; Burd EM
  • Acute cholecystitis caused by nontoxigenic Vibrio cholerae O1 Inaba.
    J Clin Microbiol Volume: 48 Page(s): 1002 - 1004
    03/01/2010 Authors: Vogt AP; Doshi RK; Higgins JE; Burd EM; Ribner BS; Kraft CS
  • Cross-transmission of bacterial pathogens in the intensive care unit: What lessons can we learn?
    Crit Care Med Volume: 38 Page(s): 302 - 303
    01/01/2010 Authors: Ribner BS; Steinberg JP
  • A multicenter study on optimizing piperacillin-tazobactam use: lessons on why interventions fail.
    Infect Control Hosp Epidemiol Volume: 30 Page(s): 794 - 796
    08/01/2009 Authors: Gaynes RP; Gould CV; Edwards J; Antoine TL; Blumberg HM; Desilva K; King M; Kraman A; Pack J; Ribner B
  • Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors.
    Ann Surg Volume: 250 Page(s): 10 - 16
    07/01/2009 Authors: Steinberg JP; Braun BI; Hellinger WC; Kusek L; Bozikis MR; Bush AJ; Dellinger EP; Burke JP; Simmons B; Kritchevsky SB
  • Pseudo-outbreak of Legionella pneumophila serogroup 8 infection associated with a contaminated ice machine in a bronchoscopy suite.
    Infect Control Hosp Epidemiol Volume: 30 Page(s): 461 - 466
    05/01/2009 Authors: Schuetz AN; Hughes RL; Howard RM; Williams TC; Nolte FS; Jackson D; Ribner BS
  • The effect of a quality improvement collaborative to improve antimicrobial prophylaxis in surgical patients: a randomized trial.
    Ann Intern Med Volume: 149 Page(s): 472 - W93
    10/07/2008 Authors: Kritchevsky SB; Braun BI; Bush AJ; Bozikis MR; Kusek L; Burke JP; Wong ES; Jernigan J; Davis CC; Simmons B
  • Use of a mandatory declination form in a program for influenza vaccination of healthcare workers.
    Infect Control Hosp Epidemiol Volume: 29 Page(s): 302 - 308
    04/01/2008 Authors: Ribner BS; Hall C; Steinberg JP; Bornstein WA; Chakkalakal R; Emamifar A; Eichel I; Lee PC; Castellano PZ; Grossman GD
  • Influenza vaccination of health care workers: policies and practices of hospitals in a community setting.
    Am J Infect Control Volume: 35 Page(s): 441 - 447
    09/01/2007 Authors: Gazmararian JA; Coleman M; Prill M; Hinman AR; Ribner BS; Washington ML; Janssen A; Orenstein WA
  • Knowledge, attitudes, and behaviors regarding piperacillin-tazobactam prescribing practices: results from a multicenter study.
    Infect Control Hosp Epidemiol Volume: 27 Page(s): 1274 - 1277
    11/01/2006 Authors: Antoine TL; Curtis AB; Blumberg HM; Desilva K; Fransua M; Gould CV; King M; Kraman AA; Pack J; Ribner B
  • Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement.
    Biosecur Bioterror Volume: 4 Page(s): 351 - 365
    01/01/2006 Authors: Smith PW; Anderson AO; Christopher GW; Cieslak TJ; Devreede GJ; Fosdick GA; Greiner CB; Hauser JM; Hinrichs SH; Huebner KD
  • Benefits and harms of doxycycline treatment for Gulf War veterans' illnesses: a randomized, double-blind, placebo-controlled trial.
    Ann Intern Med Volume: 141 Page(s): 85 - 94
    07/20/2004 Authors: Donta ST; Engel CC; Collins JF; Baseman JB; Dever LL; Taylor T; Boardman KD; Kazis LE; Martin SE; Horney RA
  • Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
    J Infect Dis Volume: 174 Page(s): 537 - 543
    09/01/1996 Authors: Donta ST; Peduzzi P; Cross AS; Sadoff J; Haakenson C; Cryz SJ; Kauffman C; Bradley S; Gafford G; Elliston D
  • Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.
    Antimicrob Agents Chemother Volume: 37 Page(s): 1334 - 1342
    06/01/1993 Authors: Walsh TJ; Standiford HC; Reboli AC; John JF; Mulligan ME; Ribner BS; Montgomerie JZ; Goetz MB; Mayhall CG; Rimland D
  • Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management.
    Am J Med Volume: 94 Page(s): 313 - 328
    03/01/1993 Authors: Mulligan ME; Murray-Leisure KA; Ribner BS; Standiford HC; John JF; Korvick JA; Kauffman CA; Yu VL
  • Antibiotic resistance in long-term care facilities.
    Infect Control Hosp Epidemiol Volume: 12 Page(s): 245 - 250
    04/01/1991 Authors: John JF; Ribner BS
  • An effective educational program to reduce the frequency of needle recapping.
    Infect Control Hosp Epidemiol Volume: 11 Page(s): 635 - 638
    12/01/1990 Authors: Ribner BS; Ribner BS
  • Outbreak of multiply resistant Staphylococcus aureus in a pediatric intensive care unit after consolidation with a surgical intensive care unit.
    Am J Infect Control Volume: 17 Page(s): 244 - 249
    10/01/1989 Authors: Ribner BS; Landry MN; Kidd K; Peninger M; Riddick J
  • Protein fingerprinting for the determination of relatedness in Acinetobacter calcoaceticus subspecies anitratus isolated from patients in a surgical intensive care unit.
    Infect Control Volume: 8 Page(s): 512 - 515
    12/01/1987 Authors: Mortensen JE; LaRocco MT; Steiner B; Ribner B
  • Endemic, multiply resistant Staphylococcus aureus in a pediatric population. Clinical description and risk factors.
    Am J Dis Child Volume: 141 Page(s): 1183 - 1187
    11/01/1987 Authors: Ribner BS
  • Impact of a rigid, puncture resistant container system upon needlestick injuries.
    Infect Control Volume: 8 Page(s): 63 - 66
    02/01/1987 Authors: Ribner BS; Landry MN; Gholson GL; Linden LA
  • Strict versus modified isolation for prevention of nosocomial transmission of methicillin-resistant Staphylococcus aureus.
    Infect Control Volume: 7 Page(s): 317 - 320
    06/01/1986 Authors: Ribner BS; Landry MN; Gholson GL
  • Empirical use of imipenem as the sole antibiotic in the treatment of serious infections.
    J Antimicrob Chemother Volume: 16 Page(s): 499 - 507
    10/01/1985 Authors: Freimer EH; Donabedian H; Raeder R; Ribner BS
  • T lymphocyte abnormalities in disseminated histoplasmosis.
    Am J Med Volume: 75 Page(s): 790 - 794
    11/01/1983 Authors: Lehmann PF; Gibbons J; Senitzer D; Ribner BS; Freimer EH
  • Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis.
    Clin Pharmacol Ther Volume: 34 Page(s): 673 - 680
    11/01/1983 Authors: Gross ML; Somani P; Ribner BS; Raeader R; Freimer EH; Higgins JT
  • A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin.
    J Antimicrob Chemother Volume: 12 Page(s): 387 - 391
    10/01/1983 Authors: Ribner BS; Raeder R; Hollstein M; Freimer EH
  • Treatment of serious infections with moxalactam.
    Am J Med Volume: 74 Page(s): 396 - 400
    03/01/1983 Authors: Ribner BS; Raeder R; Becker TM; Freimer EH
  • Osteomyelitis caused by viridans streptococci.
    Arch Intern Med Volume: 142 Page(s): 1739
    09/01/1982 Authors: Ribner BS; Freimer EH
  • Treatment of significant bacterial infections in adults with cefoxitin.
    Rev Infect Dis Volume: 1 Page(s): 152 - 157
    01/01/1979 Authors: Ribner BS; Billiard BS; Freimer EH
  • Clinical experience with cefoxitin sodium.
    J Antimicrob Chemother Volume: 4 Page(s): 209 - 210
    07/01/1978 Authors: Ribner BS; Freimer EH; Billiard BS
  • Oxolinic acid for the treatment of chronic gastrointestinal Shigella carriers.
    Am J Trop Med Hyg Volume: 27 Page(s): 840 - 842
    07/01/1978 Authors: Ribner BS; Freimer EH
  • Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient.
    Chest Volume: 70 Page(s): 681 - 683
    11/01/1976 Authors: Ribner B; Keusch GT; Hanna BA; Perloff M
  • Pharmacokinetic parameters of sisomicin.
    Antimicrob Agents Chemother Volume: 10 Page(s): 25 - 27
    07/01/1976 Authors: Meyers BR; Hirschman SZ; Yancovitz S; Ribner B
  • Pharmacological studies with cefamandole in human volunteers.
    Antimicrob Agents Chemother Volume: 9 Page(s): 140 - 144
    01/01/1976 Authors: Meyers BR; Ribner B; Yancovitz S; Hirschman SZ
  • Letter: Staphylococcus aureus antigen in cerebrospinal fluid cross-reactive with Haemophilus influenzae type b antiserum.
    Ann Intern Med Volume: 83 Page(s): 370 - 371
    09/01/1975 Authors: Ribner B; Keusch GT; Robbins JB
  • Clinical studies with cefazolin: a new cephalosporin antibiotic.
    Mt Sinai J Med Volume: 42 Page(s): 142 - 149
    01/01/1975 Authors: Hammer GS; Ribner BS; Meyers BR; Hirschman SZ
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements